Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces

NCT ID: NCT05867173

Last Updated: 2025-11-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-16

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Despite the success of cochlear implants, devices surgically placed in the inner ears of patients with severe hearing loss, there remains substantial variability in the overall speech perception outcomes for the children and adults who receive them. The main goals of this project are: i) to improve our understanding of how cochlear implants affect the developing auditory system, ii) apply that knowledge to test new methods for programming children and adults, and iii) to study how long it takes listeners to adapt to new cochlear implant programs over the short- and long-term. The results will improve our understanding of how the deafened auditory system develops with cochlear implant stimulation and advance clinical practice to improve hearing outcomes in cochlear implant listeners.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Deafness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Performance Assessed with Experimental Sound Processing Strategy

Patients listening to experimental cochlear implant processing strategy.

Group Type EXPERIMENTAL

Experimental Speech Processing Strategy

Intervention Type OTHER

Patient's will listen with an experimental speech processor, programmed with a dynamic focusing strategy.

Control

Patients listening to their clinical cochlear implant using their "own" processor (their everyday listening situation).

Group Type NO_INTERVENTION

No interventions assigned to this group

Experimental Control

Patients listening to experimental cochlear implant using a processing strategy like thier clinical program, a "clinical like" program.

Group Type SHAM_COMPARATOR

Experimental Speech Processing Strategy

Intervention Type OTHER

Patient's will listen with an experimental speech processor, programmed with a dynamic focusing strategy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental Speech Processing Strategy

Patient's will listen with an experimental speech processor, programmed with a dynamic focusing strategy.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult at least 18 years old
* Native speakers of American English
* Wears a cochlear implant manufactured by Advanced Bionics (Clarion Hi-Focus I or newer), Cochlear, or MED-EL


* Children at least 3 months old
* Native speakers of American English
* Wears a cochlear implant manufactured by Advanced Bionics (Clarion Hi-Focus I or newer), Cochlear, or MED-EL

* For both children and adults with a cochlear implant, some study criteria might pertain to a subset of subjects, such as a specific age at which the subjects developed a hearing loss, or was implanted.

* Unable to carry out the study protocol or tasks required in the study

Exclusion for all Normal Hearing Subjects:

* Inability to provide informed consent
* Hearing loss, or significant history of hearing related issues
* Unable to carry out the study protocol or tasks required in the study

Exclusion Criteria

Exclusion for all Cochlear Implant Subjects:

* Inability to provide informed consent
Minimum Eligible Age

3 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Massachusetts Eye and Ear Infirmary

OTHER

Sponsor Role lead

Boston Children's Hospital

OTHER

Sponsor Role collaborator

University of Washington

OTHER

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Julie G. Arenberg, CCC-A

Director of Research and Education

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Julie Arenberg

Role: PRINCIPAL_INVESTIGATOR

Massachusetts Eye and Ear

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mass Eye and Ear

Boston, Massachusetts, United States

Site Status RECRUITING

Boston Children's Hospital

Waltham, Massachusetts, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Julie Arenberg

Role: CONTACT

617-807-7904

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Julie Arenberg

Role: primary

617-807-7904

Amanda Griffin

Role: primary

781-216-3657

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MGB_2019P000239

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.